Rare diseases
Investigational molecules
Locations
Back to Spain1 063 clinical trials in Malaga, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections
SpainStudy on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy
SpainStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
SpainStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
SpainStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
SpainStudy of Elafibranor for Adults with Primary Biliary Cholangitis
SpainStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
SpainStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
SpainStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SpainStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
SpainStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
SpainStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
SpainThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for cutaneous lupus erythematosus and myasthenia gravis, evaluating new therapeutic approaches to improve patient outcomes.
Studies aim to assess novel therapies' effectiveness in reducing disease activity and improving daily living activities.
Innovative vaccine development studies targeting COVID-19, cytomegalovirus, and respiratory syncytial virus, focusing on prevention and immune response.
Research emphasizes safety and immunogenicity in various population groups.
Advanced studies in bladder cancer, colorectal cancer, and gastric cancer, evaluating targeted therapies and combination treatments.
Trials focus on improving survival rates and treatment responses in various cancer types.
Research examining new treatments for chronic rhinosinusitis and COPD, with emphasis on symptom management and exacerbation prevention.
Studies evaluate novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
